Total words: 1317 | 2-word phrases: 349 | 3-word phrases: 367 | 4-word phrases: 374
Title | Try to keep the title under 60 characters (101 characters) Edesa Biotech, Inc. (Nasdaq: EDSA) – Clinical Stage Treatments for Immuno-Inflammatory Diseases |
Description | Try to keep the meta description between 50 - 160 characters (0 characters) |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (66 characters) Novel Experimental Treatments for Immune and Inflammatory Diseases |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | the | 17 | 7.49% | ||||||
2 | or | 12 | 5.29% | ||||||
3 | to | 10 | 4.41% | ||||||
4 | of | 9 | 3.96% | ||||||
5 | for | 8 | 3.52% | ||||||
6 | a | 7 | 3.08% | ||||||
7 | is | 7 | 3.08% | ||||||
8 | and | 7 | 3.08% | ||||||
9 | edesa | 6 | 2.64% | ||||||
10 | preferences | 6 | 2.64% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://feeds.issuerdirect.com/news-release.html?newsid=6900384097451716 | Whois | issuerdirect.com |
2 | https://cookiedatabase.org/tcf/purposes/ | Whois | cookiedatabase.org |